Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Camilla Moreira Ribeiro PhD"'
Autor:
Isabela Rodrigues Tavares MD, Roberto Augusto Caffaro MD, PhD, Maria Fernanda Portugal MD, PhD, Camilla Moreira Ribeiro PhD, Viviane Santana da Silva MD, Emily Krupa MD, Srdjan Nikolovski MD, Karen Falcão de Britto MD, Ana Cláudia Gomes Pereira Petisco MD, Maria Cristina Miranda MD, Sandra Gomes de Souza Santos MD, Marcela da Silva Dourado MD, Paula Veloso Siqueira PhD, Fakiha Siddiqui PhD, Jawed Fareed PhD, Eduardo Ramacciotti MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), represents a substantial healthcare challenge. Provoked and unprovoked DVT cases carry distinct risks and treatment considerations. Recognizing the limi
Externí odkaz:
https://doaj.org/article/e4e12f55ac934fa3bb9edb99f649170a
Autor:
Eduardo Ramacciotti MD, PhD, Leandro Barile Agati PhD, Giuliano Giova Volpiani MD, Karen Falcão Brito MD, Camilla Moreira Ribeiro PhD, Valéria Cristina Resende Aguiar MD, Lorenzo Storino Ramacciotti, Alexia Paganotti, Felipe Menegueti Pereira, Roberto Augusto Caffaro MD, PhD, Alexandre Fioranelli MD, PhD, Rogério Krakauer MD, Heron Rhydan Saad Rached, Nelson Wolosker MD, PhD, Sonia S. Anand MD, John W. Eikelboom MBBS, Renato Delascio Lopes MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Background The COMPASS trial demonstrated that in patients with peripheral arterial disease, the combination of rivaroxaban and aspirin compared with aspirin reduces the risk of major adverse limb events, but it is not known whether this combination
Externí odkaz:
https://doaj.org/article/5a29b0514e6c4f09880b84a9f73782d8